Physician profile
David Mark Schleider
NPI 1821214669
$5,732.66
in general payments reported to CMS, 2019-2025
9 companies · $436 in 2025
The $436 reported for 2025 was more than what 78% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $1,702 · 2021: $91.70 · 2022: $826 · 2023: $107 · 2024: $1,883 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,270 · Food and Beverage: $890 · Entertainment: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,270.20 |
| Food and Beverage | $889.68 |
| Entertainment | $265.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $2,530.03 | 2019-2025 | |
| Zimvie INC. | $1,941.25 | 2022-2025 | |
| Keystone Dental INC. | $813.83 | 2019-2022 | |
| Biohorizons Implant Systems INC. | $156.96 | 2019-2020 | |
| Dentsply Sirona INC | $111.55 | 2019-2024 | Astra Tech Implant System, Cavitron |
| Zimmer Biomet Holdings, INC. | $108.10 | 2019-2021 | |
| Envista Holdings Corporation | $28.74 | 2024 | Zirconia Abutment Preparation Kit |
| Colgate Oral Pharmaceuticals, INC. | $27.38 | 2023 | |
| Voco America INC. | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schleider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.